Pfizer said on Thursday it will stop global development and commercialization of its hemophilia gene therapy, Beqvez, citing ...

The misconception that women are just “carriers” has persisted for decades. We aren’t given the same access to care. Some of us aren’t diagnosed until adulthood — after years of unexplained bleeding, ...

[1–2] Failure of these regulatory pathways could result in either abnormal clot formation or excessive bleeding ... Individualized healthcare in clotting disorders has been, and will continue ...

The hemophilia market is expected to experience significant growth due to advancements in gene therapy, innovative treatments, and an increasing focus on personalized medicine. Rising awareness and ...

Researchers at the University of North Carolina (UNC) have discovered that adenovirus, a common virus that causes colds and ...

Abnormal uterine (womb) bleeding is a common problem in women. Abnormal uterine bleeding can occur as either a change in your normal menstrual period or as bleeding in between your normal menses.

Explore the genetic findings in 527 rare bleeding disorder cases, presented at EAHAD 2024, shedding light on novel variants.

A team of researchers have made a new discovery in the field of hematology, providing an explanation for spontaneous and ...

It can help doctors identify potential health complications related to wound healing, bleeding disorders, and blood clotting. The general range for adult platelets has been 150,000–450,000 ...

Researchers found this new blood clotting disorder to have certain similarities to vaccine-induced immune thrombocytopenia and thrombosis (VITT) -- a rare but aggressive clotting disorder that was ...